摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

N-benzyl-6-methyl-2-(naphthalene-2-yl)imidazo[1,2-a]pyridine-3-amine

中文名称
——
中文别名
——
英文名称
N-benzyl-6-methyl-2-(naphthalene-2-yl)imidazo[1,2-a]pyridine-3-amine
英文别名
N-benzyl-6-methyl-2-naphthalen-2-ylimidazo[1,2-a]pyridin-3-amine
N-benzyl-6-methyl-2-(naphthalene-2-yl)imidazo[1,2-a]pyridine-3-amine化学式
CAS
——
化学式
C25H21N3
mdl
——
分子量
363.462
InChiKey
BQKJEGPNOWKTSQ-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    6.8
  • 重原子数:
    28
  • 可旋转键数:
    4
  • 环数:
    5.0
  • sp3杂化的碳原子比例:
    0.08
  • 拓扑面积:
    29.3
  • 氢给体数:
    1
  • 氢受体数:
    2

反应信息

  • 作为产物:
    描述:
    苄异腈 、 (5-methyl-pyridin-2-yl)-naphthalen-2-ylmethylene-amine 以 甲醇 为溶剂, 以197 mg的产率得到N-benzyl-6-methyl-2-(naphthalene-2-yl)imidazo[1,2-a]pyridine-3-amine
    参考文献:
    名称:
    Nonacidic Farnesoid X Receptor Modulators
    摘要:
    As a cellular bile acid sensor, farnesoid X receptor (FXR) participates in regulation of bile acid, lipid and glucose homeostasis, and liver protection. Clinical results have validated FXR as therapeutic target in hepatic and metabolic diseases. To date, potent FXR agonists share a negatively ionizable function that might compromise their pharmacokinetic distribution and behavior. Here we report the development and characterization of a high-affinity FXR modulator not comprising an acidic residue.
    DOI:
    10.1021/acs.jmedchem.7b00903
点击查看最新优质反应信息

文献信息

  • Microwave-assisted multi-component synthesis of fused 3-aminoimidazoles
    作者:Sarah M. Ireland、Heather Tye、Mark Whittaker
    DOI:10.1016/s0040-4039(03)00941-9
    日期:2003.6
    A variety of fused 3-aminoimidazoles have been synthesised by a microwave assisted Ugi three-component Coupling (3cc) reaction catalysed by scandium triflate in methanol as solvent. Yields of 33-93% have been achieved after just 10 mill of microwave irradiation using a simple one-stage procedure. The methodology described is suitable for the rapid and efficient synthesis of a range of fused heterocycles of pharmacological interest. (C) 2003 Elsevier Science Ltd. All rights reserved.
  • Nonacidic Farnesoid X Receptor Modulators
    作者:Daniel Flesch、Sun-Yee Cheung、Jurema Schmidt、Matthias Gabler、Pascal Heitel、Jan Kramer、Astrid Kaiser、Markus Hartmann、Mara Lindner、Kerstin Lüddens-Dämgen、Jan Heering、Christina Lamers、Hartmut Lüddens、Mario Wurglics、Ewgenij Proschak、Manfred Schubert-Zsilavecz、Daniel Merk
    DOI:10.1021/acs.jmedchem.7b00903
    日期:2017.8.24
    As a cellular bile acid sensor, farnesoid X receptor (FXR) participates in regulation of bile acid, lipid and glucose homeostasis, and liver protection. Clinical results have validated FXR as therapeutic target in hepatic and metabolic diseases. To date, potent FXR agonists share a negatively ionizable function that might compromise their pharmacokinetic distribution and behavior. Here we report the development and characterization of a high-affinity FXR modulator not comprising an acidic residue.
查看更多